Mounjaro Shortages and Supply Issues UK: Current Status and What to Do

Where supply stands now

As of September 2026, Mounjaro is in normal supply across UK private pharmacies at every strength from 2.5mg to 15mg. National shortages have not recurred since the 2025 episode described below. What does still happen is local gaps: a single pharmacy running out of one dose for a few days, usually after a price cut brings a rush of orders, or around a bank holiday. Those gaps resolve quickly and the fix is to check stock before you pay, or to order from another verified pharmacy. Our price list is updated as pharmacies change prices and availability.

The bigger constraint since autumn 2025 has been price, not stock. In September 2025 Eli Lilly raised UK list prices sharply, with the top doses roughly doubling. Pharmacies absorbed some of that through supplier discounts, but monthly costs rose across the board and treatment became harder to sustain for many people. Our Mounjaro cost guide tracks where prices are now.

What happened in 2025

In March 2025 the UK ran short of the two highest strengths, the 12.5mg and 15mg pens. Eli Lilly confirmed supply disruption, lower doses stayed largely available, and thousands of people who had titrated up over months found their dose out of stock at pharmacy after pharmacy. Lilly prioritised existing patients and pointed to a gradual recovery from mid to late April. In practice stock returned unevenly: some online pharmacies were back within weeks, others took longer, and availability varied day to day for most of the spring.

A second, smaller disruption followed in August 2025 around the announcement of the price rise, when demand spiked as people tried to buy ahead of it. Some pharmacies oversold, orders were cancelled weeks after payment, and processing times stretched to over a week at a few providers. By late September supply had normalised and the problem became cost.

Why it happened

• Global demand outran manufacturing. Tirzepatide was launching in new markets at the same time, and injector pen production is slow to scale.
• The top doses are where patients accumulate. Most people move up the dose ladder and stay at 12.5mg or 15mg, so those strengths carry the most demand and the least slack.
• Private UK supply is a long chain. Manufacturer, wholesaler, pharmacy, courier. A delay at any link showed up as an empty basket at checkout.
• Buying ahead makes it worse. When people stockpile before a price change, the queue lengthens for everyone, including people who rely on tirzepatide for type 2 diabetes.

What to do if your dose is out of stock

1. Check stock before you pay. Some pharmacies accept orders they cannot fill. Call or message first if the site does not show live availability. Smaller pharmacies tend to give straighter answers than large ones.
2. Try another verified pharmacy. Gaps are usually local. Our switching pharmacy guide covers moving with a dose in hand; pen-box photos and order screenshots are the evidence you need.
3. Ask your prescriber about a temporary step down. During 2025 many people moved from 15mg to 12.5mg, or 12.5mg to 10mg, rather than break treatment. That is a prescriber decision, never a pharmacy offer, and never something to do on your own.
4. Do not split or stretch pens. Our running out between pens guide explains what is and is not sensible.
5. Do not stockpile. Pens have a 30-day limit once out of the fridge and hoarding lengthens the queue for everyone.
6. Be sceptical of stock rumours. Affiliates sometimes spread shortage claims to push traffic to a rival pharmacy. Check the pharmacy’s own site or support team.

Lessons that still apply

• Reorder with a week of doses left, not on the day you run out. A buffer turns a stock gap into an inconvenience rather than a missed dose.
• Keep a second pharmacy ready. An account and ID check with a backup provider means a switch takes days, not weeks.
• Talk to the prescriber early. A planned step down is far better than an unplanned break.
• Compare across pharmacies rather than relying on one. That is what a price comparison is for.

Could it happen again?

Manufacturing capacity has grown since 2025, the UK has more pharmacies stocking every strength, and the September 2025 price rise reduced demand pressure. A national shortage on the 2025 scale is less likely, but not impossible: a large NHS expansion, a sudden price cut, or a manufacturing problem could tighten supply again. The protection is the same as it was. Order early, know a backup pharmacy, and check stock and price across verified providers before you pay. If you experience a shortage, tell Monj; reports from readers are how we spot problems pharmacies do not announce.